These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3383549)

  • 21. Activity of cefamandole, cefoxitin, ampicillin and gentamicin against 419 bacteria isolated from blood of patients with sepsis.
    Mirrett S; Reller LB
    Chemotherapy; 1980; 26(6):436-45. PubMed ID: 7408556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates.
    Owens RC; Banevicius MA; Nicolau DP; Nightingale CH; Quintiliani R
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2586-8. PubMed ID: 9371376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics.
    Vanhoof R; Gordts B; Coignau H; Stas G; Butzler JP
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():63-6. PubMed ID: 19802970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amdinocillin in combination with beta-lactam antibiotics for treatment of serious gram-negative infections.
    Rotstein C; Farrar WE
    Am J Med; 1983 Aug; 75(2A):96-9. PubMed ID: 6311014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
    Wang FD; Lin ML; Lee WS; Liu CY
    Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic considerations in using combinations of newer beta-lactam antibiotics.
    Barriere SL
    Clin Pharm; 1986 Jan; 5(1):24-33. PubMed ID: 3512153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latamoxef in combination with aminoglycosides against Pseudomonas aeruginosa: similarity with ticarcillin.
    Sears SD; Tatem BA; Standiford HC
    Chemotherapy; 1985; 31(2):102-11. PubMed ID: 3921317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections.
    Naber KG; Wittenberger R
    Rev Infect Dis; 1986; 8 Suppl 5():S604-8. PubMed ID: 3026011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics.
    Paglia P; Molinari G; Pesce A; Debbia EA
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):639-43. PubMed ID: 2506028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative activities of 15 beta-lactam antibiotics against 590 strains of Klebsiella pneumoniae according to the production of beta-lactamase].
    Bercion R; Meyran M; Labia R; Thabaut A
    Pathol Biol (Paris); 1991 May; 39(5):353-60. PubMed ID: 1881669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.
    Kuo HY; Wang FD; Yen YF; Lin ML; Liu CY
    New Microbiol; 2009 Jan; 32(1):49-55. PubMed ID: 19382669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents.
    Aldridge KE; Henderberg A; Sanders CV
    J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro synergistic activity of piperacillin-tazobactam combination against beta-lactam antibiotics resistant strains of Enterobacteriaceae].
    Duex JM; Cordin X; Péchinot A; Siebor E; Kazmierczak A
    Pathol Biol (Paris); 1991 May; 39(5):374-8. PubMed ID: 1652728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.